NFKB1 and hepatocellular carcinoma: Preclinical models support this bidirectional relationship: GC treatment suppresses peritumoral inflammation and angiogenesis in early‐stage hepatocellular carcinoma, whereas in certain hepatoma cell lines, GCs inhibit apoptosis by maintaining NF‐κB activity.